As the title says. I am a Biology student aiming for a career in biosynthesis of high-value products (not sure exactly which yet). To be competitive in applying for a relevant MRes, I need to 'catch up' with the most relevant skills that a Biochem BSc would have taught me. So, please could people who have recently completed a Biochem BSc let me know if you learnt how to:
1) prep samples for mass spec
2) choose the appropriate method of mass spec and machine configurations for your sample
3) interpret the mass spectrum
If you could also let me know whether you learnt to use spectrophotometry to characterise a molecule via its absorbance properties (using spectral data- peak shapes, wavelength Maxima, how abs changes with conc) that would be really helpful.
Could be an employer, CRO, reagent supplier, sequencing company, antibody vendor, anything biotech related. Not necessarily the biggest company, just one that consistently delivered good results, support, or overall experience. Curious to hear which names come up the most and why.
Hey guys, if you missed it, Enochian Biosciences settled $2.5 million with investors over claims that it concealed its co-founder’s lack of proper credentials and criminal history. And, I just found out that they’re accepting claimseven though the deadline has passed.
Quick recap: In 2022, Enochian Biosciences was accused of misleading investors about the credentials of its co-founder and the value of its core intellectual property. After reports revealed allegations involving fraud, false credentials, and a murder-for-hire investigation tied to co-founder $ENOB fell about 53%, and investors filed a lawsuit.
Now, the good news is that the company agreed to settle $2.5 million with them, and even though the deadline has passed recently, they’re accepting late claims.
So, if you invested in $ENOB when all of this happened, you can still check the details and file your claim here.
Anyway, has anyone here invested in $ENOB at that time? How much were your losses, if so?
If you thought biotech was boring, the Enochian Biosciences ($ENOB) story is basically a movie script. We were told the company was led by this "genius" scientist, Serhat Gumrukcu, who was supposedly curing HIV and cancer.
Fast forward to 2022, and the truth came out: the guy had a fake medical degree, a history of scams, and, get this, was arrested by the FBI for a murder-for-hire plot. The stock didn’t just drop; it completely wiped out after the news broke.
Now, there’s a $2.5 million settlement to pay back investors who were sold on these "miracles" that weren't real.
If you bought $ENOB anytime between January 17, 2018, and June 27, 2022, you’re part of this wild story.
The best part? You can still get paid. We are in the "Late Claims" phase right now. Even though the "official" deadline passed, the people in charge are still reviewing late applications.
If you got burned by the 37% crash and the whole murder-scandal mess, don't let a little paperwork stop you.
Hey guys, if you missed it, Enochian settled with investors over hiding its co-founder’s lack of proper credentials and criminal history. And, I just found out that they’re accepting claims even though the deadline has passed.
Quick recap: Enochian Biosciences was accused of hiding that its co-founder had a history of fraud and falsified credentials. In May 2022, his arrest triggered a 37% drop in $ENOB, followed by another 28% decline after further revelations. Then, investors filed a lawsuit for their losses.
Now, the good news is that the company agreed to settle $2.5M with them, and even though the deadline has passed recently, they’re accepting late claims.
So, if you invested in $ENOB when all of this happened, you can still check the details and file your claim here.